Identification of ZNF217, hnRNP‐K, VEGF‐A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma
Jaroslaw Szczyrba(Essen University Hospital), Friedrich A. Grässer(Saarland University), Bastian Keck(Friedrich-Alexander-Universität Erlangen-Nürnberg), Bernd Wullich(Friedrich-Alexander-Universität Erlangen-Nürnberg), Wolf F. Wieland(University of Regensburg), Celina Döll(Saarland University), Sven Wach(Friedrich-Alexander-Universität Erlangen-Nürnberg), Elke Nolte(Universitätsklinikum Erlangen), Elisabeth Kremmer(Justus-Liebig-Universität Gießen), Martin Hart(Institute of Human Genetics), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Arndt Hartmann(Universitätsklinikum Erlangen), Helge Täubert(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 73
Related Papers
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
|JAMA Oncology|2017|409
Toward the blood-borne miRNome of human diseases
|Nature Methods|2011|364
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS
|Deutsches Ärzteblatt international|2020|258